论文部分内容阅读
血栓心脉宁片是在血栓心脉宁胶囊的基础之上做的二次研发,无论在制备工艺、质量标准、知识产权、创新性及临床疗效来看都明显优于胶囊。为了进一步研究和全面总结血栓心脉宁片的临床作用机制,拓展临床用途,为更多的心脑血管疾病患者解除病痛,吉林华康药业股份有限公司与《中西?
The thrombus Xinmaining capsule is a secondary research and development made on the basis of thrombus Xinmaining Capsule, which is obviously superior to capsules in terms of preparation technique, quality standard, intellectual property, innovation and clinical curative effect. In order to further study and comprehensively summarize the clinical mechanism of thrombosis Xinmaining capsule, expand clinical use and relieve the pain for more patients with cardiovascular and cerebrovascular diseases, Jilin Huakang Pharmaceutical Co., Ltd. and "